Predicting COVID-19 progression in hospitalized patients in Kurdistan Province using a multi-state model.

IF 1.6 Q4 ENDOCRINOLOGY & METABOLISM
Journal of Diabetes and Metabolic Disorders Pub Date : 2025-03-22 eCollection Date: 2025-06-01 DOI:10.1007/s40200-025-01576-x
Shnoo Bayazidi, Ghobad Moradi, Safdar Masoumi, Seyed Amin Setarehdan, Hamid Reza Baradaran
{"title":"Predicting COVID-19 progression in hospitalized patients in Kurdistan Province using a multi-state model.","authors":"Shnoo Bayazidi, Ghobad Moradi, Safdar Masoumi, Seyed Amin Setarehdan, Hamid Reza Baradaran","doi":"10.1007/s40200-025-01576-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to implement a multi-state risk prediction model to predict the progression of COVID-19 cases among hospitalized patients in Kurdistan province by analyzing hospital care data.</p><p><strong>Methods: </strong>This retrospective analysis consisted of data from 17,286 patients admitted to hospitals with COVID-19 from March 23, 2019, to December 19, 2021, in various areas in the Kurdistan province. A multi-state prediction model was used to show that each transition is predicted by a different set of variables. These variables include underlying diseases (like diabetes, hypertension, etc.) and sociodemographic information (like sex and age). Model aims to predict the likelihood of recovery, the need for critical care intervention (e.g., transfer to isolation units or the ICU), or exits from the hospitalization course. We performed the statistical analysis using R software and the mstate package.</p><p><strong>Results: </strong>Of the hospitalized patients studied, 5.6% died of the disease, 6.6% were admitted to ICUs, and 38.72% were treated in isolation units. Mortality rates in general wards, isolation units, and the ICU were 3.48%, 4.56%, and 26.6%, respectively. Significant predictors for ICU admission include age over 60 years (HR: 1.46, 95% CI 1.37-1.55), kidney-related conditions (HR: 2.19, 95% CI 1.65-2.91), cardiovascular diseases (HR: 1.68, 95% CI 1.46-1.94), lung disease (HR: 1.89,‏95% CI 1.43-2.05), and cancer (HR: 2.46,‏95% CI 1.77-3.41). The likelihood of in-hospital death is significantly increased by age over 60 years (HR: 2.40, 95% CI 2.09-2.76), diabetes (HR: 1.97, 95% CI 1.45-2.68), high blood pressure (HR: 2.30, 95% CI 1.78-2.97), and history of heart disease (HR: 3.01, 95% CI 2.29-3.95).</p><p><strong>Conclusion: </strong>The model helps the provider and policymakers to make an informed decision depending on patient management and resource allocation within the health care systems.</p>","PeriodicalId":15635,"journal":{"name":"Journal of Diabetes and Metabolic Disorders","volume":"24 1","pages":"88"},"PeriodicalIF":1.6000,"publicationDate":"2025-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11929647/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Diabetes and Metabolic Disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40200-025-01576-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: This study aimed to implement a multi-state risk prediction model to predict the progression of COVID-19 cases among hospitalized patients in Kurdistan province by analyzing hospital care data.

Methods: This retrospective analysis consisted of data from 17,286 patients admitted to hospitals with COVID-19 from March 23, 2019, to December 19, 2021, in various areas in the Kurdistan province. A multi-state prediction model was used to show that each transition is predicted by a different set of variables. These variables include underlying diseases (like diabetes, hypertension, etc.) and sociodemographic information (like sex and age). Model aims to predict the likelihood of recovery, the need for critical care intervention (e.g., transfer to isolation units or the ICU), or exits from the hospitalization course. We performed the statistical analysis using R software and the mstate package.

Results: Of the hospitalized patients studied, 5.6% died of the disease, 6.6% were admitted to ICUs, and 38.72% were treated in isolation units. Mortality rates in general wards, isolation units, and the ICU were 3.48%, 4.56%, and 26.6%, respectively. Significant predictors for ICU admission include age over 60 years (HR: 1.46, 95% CI 1.37-1.55), kidney-related conditions (HR: 2.19, 95% CI 1.65-2.91), cardiovascular diseases (HR: 1.68, 95% CI 1.46-1.94), lung disease (HR: 1.89,‏95% CI 1.43-2.05), and cancer (HR: 2.46,‏95% CI 1.77-3.41). The likelihood of in-hospital death is significantly increased by age over 60 years (HR: 2.40, 95% CI 2.09-2.76), diabetes (HR: 1.97, 95% CI 1.45-2.68), high blood pressure (HR: 2.30, 95% CI 1.78-2.97), and history of heart disease (HR: 3.01, 95% CI 2.29-3.95).

Conclusion: The model helps the provider and policymakers to make an informed decision depending on patient management and resource allocation within the health care systems.

使用多州模型预测库尔德斯坦省住院患者的COVID-19进展
目的:通过分析库尔德斯坦省住院患者的医院护理数据,建立多状态风险预测模型,预测2019冠状病毒病(COVID-19)病例的进展。方法:回顾性分析2019年3月23日至2021年12月19日在库尔德斯坦省不同地区入院的17286例COVID-19患者的资料。采用多状态预测模型,表明每一次过渡都由一组不同的变量来预测。这些变量包括潜在疾病(如糖尿病、高血压等)和社会人口统计信息(如性别和年龄)。模型旨在预测康复的可能性,对重症监护干预的需求(例如,转移到隔离病房或ICU),或从住院过程中退出。我们使用R软件和mstate包进行统计分析。结果:5.6%的住院患者死于该病,6.6%的患者入住icu, 38.72%的患者在隔离病房接受治疗。普通病房、隔离病房和ICU的死亡率分别为3.48%、4.56%和26.6%。ICU入院的重要预测因素包括年龄超过60岁(HR: 1.46, 95% CI 1.37-1.55)、肾脏相关疾病(HR: 2.19, 95% CI 1.65-2.91)、心血管疾病(HR: 1.68, 95% CI 1.46-1.94)、肺部疾病(HR: 1.89, 95% CI 1.43-2.05)和癌症(HR: 2.46, 95% CI 1.77-3.41)。住院死亡的可能性随着年龄超过60岁(HR: 2.40, 95% CI 2.09-2.76)、糖尿病(HR: 1.97, 95% CI 1.45-2.68)、高血压(HR: 2.30, 95% CI 1.78-2.97)和心脏病史(HR: 3.01, 95% CI 2.29-3.95)而显著增加。结论:该模型有助于医疗服务提供者和决策者根据患者管理和卫生保健系统内的资源分配情况做出明智的决策。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Diabetes and Metabolic Disorders
Journal of Diabetes and Metabolic Disorders Medicine-Internal Medicine
CiteScore
4.80
自引率
3.60%
发文量
210
期刊介绍: Journal of Diabetes & Metabolic Disorders is a peer reviewed journal which publishes original clinical and translational articles and reviews in the field of endocrinology and provides a forum of debate of the highest quality on these issues. Topics of interest include, but are not limited to, diabetes, lipid disorders, metabolic disorders, osteoporosis, interdisciplinary practices in endocrinology, cardiovascular and metabolic risk, aging research, obesity, traditional medicine, pychosomatic research, behavioral medicine, ethics and evidence-based practices.As of Jan 2018 the journal is published by Springer as a hybrid journal with no article processing charges. All articles published before 2018 are available free of charge on springerlink.Unofficial 2017 2-year Impact Factor: 1.816.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信